Pharmacokinetics: Drug–Food and Drug–Viral Interactions

Grapefruit juice inhibits CYP3A4, a key metabolic enzyme responsible for breaking down many drugs. This inhibition slows drug metabolism, causing increased drug concentrations in the bloodstream and raising the risk of toxicity. A documented case involved a man who experienced fatal cardiac toxicity after consuming grapefruit juice with terfenadine, an antihistamine.

High-protein diets and charcoal-broiled foods increase the metabolism of theophylline, a bronchodilator used to treat respiratory diseases. This increased metabolism accelerates drug clearance from the body, potentially reducing therapeutic effectiveness. Dosing adjustments may be necessary to maintain adequate drug concentrations for treatment.

Aspirin use in children exposed to influenza B or varicella zoster viral infections can trigger Reye's syndrome, a rare but serious condition causing severe liver dysfunction and brain swelling. The exact mechanism of this drug-viral interaction remains poorly understood, yet the consequences are severe, making this interaction clinically significant.

Drug interactions can alter either pharmacokinetics or pharmacodynamics. Pharmacokinetic interactions affect how the body processes a drug—absorption, metabolism, and excretion—such as grapefruit juice inhibiting CYP3A4. Pharmacodynamic interactions modify the drug's action at its target site, impacting safety and efficacy differently than kinetic changes.

Drug-food interactions can significantly impact drug absorption, metabolism, and excretion, leading to altered drug concentrations and potential toxicity or reduced efficacy. Recognizing these interactions is crucial for optimizing treatment outcomes and minimizing risks, particularly given the variation in dietary habits across different patient populations.

The cytochrome P450 enzyme system, particularly CYP3A4, metabolizes many medications. When foods like grapefruit juice inhibit these enzymes, drug metabolism slows, causing drug accumulation. Conversely, foods that induce these enzymes can accelerate metabolism, reducing drug effectiveness and requiring dose adjustments.

Drug-viral interactions, such as aspirin triggering Reye's syndrome in children with influenza or varicella infections, remain poorly understood mechanistically. Despite limited knowledge of how viruses and drugs interact at the molecular level, these interactions can produce severe consequences, highlighting the need for careful medication management in patients with viral infections.